MC
LLY icon

Martin & Co’s Eli Lilly LLY Stock Holding History

Martin & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Hold
232
– – 0.04% 100
2026
Q1 		$213K Hold
232
– – 0.04% 101
2025
Q4 		$249K Buy
+232
New +$222K 0.04% 100
2024
Q4 		– Sell
-232
Closed -$206K – 103
2024
Q3 		$206K Hold
232
– – 0.05% 106
2024
Q2 		$210K Buy
+232
New +$186K 0.05% 105

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Martin & Co's LLY Position: Q2 2026 in Review

Martin & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 232 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #100.

Martin & Co first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Martin & Co held 232 shares of Eli Lilly worth $278K as of Q2 2026.
  • Martin & Co left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.04% of Martin & Co's portfolio in Q2 2026, its #100 holding.
  • Martin & Co first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.